A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD

A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD

Abstract The swift transmission rate and unfavorable prognosis associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have prompted the pursuit of more effective therapeutic interventions. Azithromycin (AZM) has garnered significant attention for its distinctive pharmacological...

Full description

Saved in:
Bibliographic Details
Main Authors: Yining Xie, Guangshu Chen, Weiling Wu, Xueman Wen, Meizheng Lai, Li Che, Jianmin Ran
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
COPD
IPF
SARS-Cov-2
Azithromycin
Bioinformatics
Online Access:https://doi.org/10.1038/s41598-025-94801-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-94801-9

Similar Items